◆英語タイトル：Aratana Therapeutics Inc. (PETX) - Financial and Strategic SWOT Analysis Review
◆レポート形式：英語 / PDF
Aratana Therapeutics, Inc. (Aratana) is an animal health company that develops and markets biopharmaceutical products for medical condition in cats and dogs. It is developing novel pet therapeutics for unmet and underserved medical needs of dogs and cats. It has developed two canine-specific monoclonal antibody (MAb) therapies AT-005 and AT-004 for the treatment of lymphoma in dogs. It is also conducting research and development of AT-014 to treat osteosarcoma in dogs and AT-009 to treat canine mast cell tumors. Aratana is developing a non-opioid pain relief drug AT-001, for dogs with osteoarthritis that uses a compound to block receptors in pain and inflammation. It is developing an appetite stimulant, AT002 for treating inappetence in dogs and cats. It is developing pain- relief drugs such as AT-003 for post-operative pain in both dogs and cats. The company is developing AT-006, an eye drop solution for treating ocular diseases caused by acute herpes-related virus in cats. Aratana is also developing small molecule and monoclonal antibody therapies for treating atopic dermatitis in dogs. It has operational presence in Belgium and the US. Aratana is headquartered in Kansas City, Kansas, the US.
Aratana Therapeutics Inc. Key Recent Developments
Jul 22, 2015: Aratana Therapeutics Provides Update on Monoclonal Antibody Products
This comprehensive SWOT profile of Aratana Therapeutics Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aratana Therapeutics Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Aratana Therapeutics Inc. – Key Information
Aratana Therapeutics Inc. – Overview
Aratana Therapeutics Inc. – Key Employees
Aratana Therapeutics Inc. – Key Employee Biographies
Aratana Therapeutics Inc. – Key Operational Heads
Aratana Therapeutics Inc. – Major Products and Services
Aratana Therapeutics Inc. – History
Aratana Therapeutics Inc. – Company Statement
Aratana Therapeutics Inc. – Locations And Subsidiaries
Aratana Therapeutics Inc. – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Aratana Therapeutics Inc. – Business Description
Aratana Therapeutics Inc. – Corporate Strategy
Aratana Therapeutics Inc. – SWOT Analysis
SWOT Analysis – Overview
Aratana Therapeutics Inc. – Strengths
Aratana Therapeutics Inc. – Weaknesses
Aratana Therapeutics Inc. – Opportunities
Aratana Therapeutics Inc. – Threats
Aratana Therapeutics Inc. – Key Competitors
Section 3 – Company Financial Performance Charts
Aratana Therapeutics Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Aratana Therapeutics Inc., Key Information
Aratana Therapeutics Inc., Key Ratios
Aratana Therapeutics Inc., Share Data
Aratana Therapeutics Inc., Major Products and Services
Aratana Therapeutics Inc., History
Aratana Therapeutics Inc., Key Employees
Aratana Therapeutics Inc., Key Employee Biographies
Aratana Therapeutics Inc., Key Operational Heads
Aratana Therapeutics Inc., Other Locations
Aratana Therapeutics Inc., Subsidiaries
Aratana Therapeutics Inc., Key Manufacturing facilities
Aratana Therapeutics Inc., Key Competitors
Aratana Therapeutics Inc., SWOT Analysis
Aratana Therapeutics Inc., Ratios based on current share price
Aratana Therapeutics Inc., Annual Ratios
Aratana Therapeutics Inc., Interim Ratios
Capital Market Ratios
List of Figures
Aratana Therapeutics Inc., Performance Chart
Aratana Therapeutics Inc., Ratio Charts
Aratana Therapeutics Inc. (PETX)：企業の財務及び戦略的SWOT分析(Aratana Therapeutics Inc. (PETX) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。